{"id":"https://openalex.org/W2000489601","doi":"https://doi.org/10.1016/0959-8049(95)00565-x","title":"Pharmacokinetics and pharmacodynamics of nitrosourea fotemustine: A French cancer centre multicentric study","display_name":"Pharmacokinetics and pharmacodynamics of nitrosourea fotemustine: A French cancer centre multicentric study","alternate_titles":[],"publication_year":1996,"publication_date":"1996-03-01","ids":{"openalex":"https://openalex.org/W2000489601","doi":"https://doi.org/10.1016/0959-8049(95)00565-x","mag":"2000489601","pmid":"https://pubmed.ncbi.nlm.nih.gov/8814692"},"language":"en","primary_location":{"id":"doi:10.1016/0959-8049(95)00565-x","doi":"https://doi.org/10.1016/0959-8049(95)00565-x","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0959-8049(95)00565-x","pdf_url":null,"source":{"id":"https://openalex.org/S16731738","display_name":"European Journal of Cancer","issn_l":"0959-8049","issn":["0959-8049","1879-0852"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Cancer","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2000489601"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5034342468","display_name":"Athanassios Iliadis","orcid":"https://orcid.org/0000-0003-0484-1213","observed_orcids":["https://orcid.org/0000-0003-0484-1213"]},"institutions":[{"id":"https://openalex.org/I21491767","display_name":"Aix-Marseille Universit\u00e9","ror":"https://ror.org/035xkbk20","country_code":"FR","type":"education","lineage":["https://openalex.org/I21491767"]}],"countries":["FR"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"A. Iliadis","raw_affiliation_strings":["Facult\u00e9 de Pharmacie, Marseille, France","Facult\u00e9de Pharmacie, 27 bid Jean Moulin, 13385 Marseille C\u00e9dex 05, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Facult\u00e9 de Pharmacie, Marseille, France","institution_ids":[]},{"raw_affiliation_string":"Facult\u00e9de Pharmacie, 27 bid Jean Moulin, 13385 Marseille C\u00e9dex 05, France","institution_ids":["https://openalex.org/I21491767"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052316842","display_name":"M. C. Launay-Iliadis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I21491767","display_name":"Aix-Marseille Universit\u00e9","ror":"https://ror.org/035xkbk20","country_code":"FR","type":"education","lineage":["https://openalex.org/I21491767"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M.-C. Launay-Iliadis","raw_affiliation_strings":["Facult\u00e9de Pharmacie, 27 bid Jean Moulin, 13385 Marseille C\u00e9dex 05, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Facult\u00e9de Pharmacie, 27 bid Jean Moulin, 13385 Marseille C\u00e9dex 05, France","institution_ids":["https://openalex.org/I21491767"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082125502","display_name":"Catherine J. Lucas","orcid":"https://orcid.org/0000-0002-8126-5582","observed_orcids":["https://orcid.org/0000-0002-8126-5582"]},"institutions":[{"id":"https://openalex.org/I4405268767","display_name":"Institut de Recherches Internationales Servier (France)","ror":"https://ror.org/01zej3n42","country_code":"FR","type":"company","lineage":["https://openalex.org/I4405268767"]}],"countries":["FR"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"C. Lucas","raw_affiliation_strings":["IRIS, Division Th\u00e9rapeutique Canc\u00e9rologie, 6 place des Pl\u00e9iades, 92415 Courbevoie C\u00e9dex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IRIS, Division Th\u00e9rapeutique Canc\u00e9rologie, 6 place des Pl\u00e9iades, 92415 Courbevoie C\u00e9dex, France","institution_ids":["https://openalex.org/I4405268767"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085471819","display_name":"R. F\u00e9ty","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"R. Fety","raw_affiliation_strings":["Laboratoire de Pharmacocin\u00e9tique, Centre Ren\u00e9Gauducheau, bid Jacques Monod, 44805 Saint Herblain C\u00e9dex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire de Pharmacocin\u00e9tique, Centre Ren\u00e9Gauducheau, bid Jacques Monod, 44805 Saint Herblain C\u00e9dex, France","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032111284","display_name":"Francois Marc Lokiec","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210116453","display_name":"H\u00f4pital Ren\u00e9 Huguenin","ror":"https://ror.org/0263jp665","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210116453"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"F. Lokiec","raw_affiliation_strings":["Laboratoire de Pharmacocin\u00e9tique, Centre Ren\u00e9Huguenin, 35 rue Dailly, 92211 Saint-Cloud C\u00e9dex, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire de Pharmacocin\u00e9tique, Centre Ren\u00e9Huguenin, 35 rue Dailly, 92211 Saint-Cloud C\u00e9dex, France","institution_ids":["https://openalex.org/I4210116453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030087673","display_name":"Brigitte Tranchand","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210105738","display_name":"Centre L\u00e9on B\u00e9rard","ror":"https://ror.org/01cmnjq37","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I4210105738"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"B. Tranchand","raw_affiliation_strings":["Laboratoire de Pharmacocin\u00e9tique, Centre L\u00e9on B\u00e9rard, 28 rue La\u00ebnnec, 69373 Lyon C\u00e9dex 08, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire de Pharmacocin\u00e9tique, Centre L\u00e9on B\u00e9rard, 28 rue La\u00ebnnec, 69373 Lyon C\u00e9dex 08, France","institution_ids":["https://openalex.org/I4210105738"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5090050048","display_name":"Gerard Alain Milano","orcid":"https://orcid.org/0000-0003-2478-0040","observed_orcids":["https://orcid.org/0000-0003-2478-0040"]},"institutions":[{"id":"https://openalex.org/I4210151846","display_name":"Centre Antoine Lacassagne","ror":"https://ror.org/05hmfw828","country_code":"FR","type":"facility","lineage":["https://openalex.org/I4210151846"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"G. Milano","raw_affiliation_strings":["Laboratoire d'Oncopharmacologie, Centre Antoine Lacassagne, 36 Voie Romaine, 06054 Nice, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Laboratoire d'Oncopharmacologie, Centre Antoine Lacassagne, 36 Voie Romaine, 06054 Nice, France","institution_ids":["https://openalex.org/I4210151846"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5034342468","https://openalex.org/A5082125502"],"corresponding_institution_ids":["https://openalex.org/I21491767","https://openalex.org/I4405268767"],"apc_list":{"value":4270,"currency":"USD","value_usd":4270},"apc_paid":null,"fwci":0.195,"has_fulltext":false,"cited_by_count":16,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.38878158,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":86,"max":94},"biblio":{"volume":"32","issue":"3","first_page":"455","last_page":"460"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.8925999999046326,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.8925999999046326,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.014999999664723873,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.014000000432133675,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/fotemustine","display_name":"fotemustine","score":0.9980000257492065},{"id":"https://openalex.org/keywords/nitrosourea","display_name":"nitrosourea","score":0.890999972820282},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.9919999837875366},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9380000233650208},{"id":"https://openalex.org/keywords/pharmacokinetic-pharmacodynamic-relationship","display_name":"pharmacokinetic-pharmacodynamic relationship","score":0.8619999885559082},{"id":"https://openalex.org/keywords/continuous-infusion","display_name":"continuous infusion","score":0.7149999737739563},{"id":"https://openalex.org/keywords/two-compartment-model","display_name":"two-compartment model","score":0.7689999938011169},{"id":"https://openalex.org/keywords/drug-clearance","display_name":"drug clearance","score":0.8550000190734863},{"id":"https://openalex.org/keywords/time-independence","display_name":"time independence","score":0.7950000166893005},{"id":"https://openalex.org/keywords/leukopenia","display_name":"leukopenia","score":0.6549999713897705},{"id":"https://openalex.org/keywords/white-blood-cell-count","display_name":"white blood cell count","score":0.8140000104904175},{"id":"https://openalex.org/keywords/area-under-the-curve","display_name":"area under the curve","score":0.8500000238418579},{"id":"https://openalex.org/keywords/high-dose-chemotherapy","display_name":"high-dose chemotherapy","score":0.7400000095367432}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.8175897598266602},{"id":"https://openalex.org/C2776946711","wikidata":"https://www.wikidata.org/wiki/Q418311","display_name":"Nitrosourea","level":3,"score":0.7753947973251343},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.6617884039878845},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.607542872428894},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5371028184890747},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3828095495700836},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34049463272094727},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.1865871250629425}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009607","descriptor_name":"Nitrosourea Compounds","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D009607","descriptor_name":"Nitrosourea Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D009607","descriptor_name":"Nitrosourea Compounds","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D009943","descriptor_name":"Organophosphorus Compounds","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D009943","descriptor_name":"Organophosphorus Compounds","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D009943","descriptor_name":"Organophosphorus Compounds","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1016/0959-8049(95)00565-x","doi":"https://doi.org/10.1016/0959-8049(95)00565-x","is_oa":false,"landing_page_url":"https://doi.org/10.1016/0959-8049(95)00565-x","pdf_url":null,"source":{"id":"https://openalex.org/S16731738","display_name":"European Journal of Cancer","issn_l":"0959-8049","issn":["0959-8049","1879-0852"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Cancer","raw_type":"journal-article"},{"id":"pmid:8814692","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8814692","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of cancer (Oxford, England : 1990)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9391000270843506,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":31,"referenced_works":["https://openalex.org/W97420631","https://openalex.org/W97766958","https://openalex.org/W368475356","https://openalex.org/W1534933987","https://openalex.org/W1727163805","https://openalex.org/W1749630649","https://openalex.org/W1764040454","https://openalex.org/W1973043144","https://openalex.org/W2006702541","https://openalex.org/W2007476234","https://openalex.org/W2044310581","https://openalex.org/W2046074703","https://openalex.org/W2052998982","https://openalex.org/W2067260393","https://openalex.org/W2071995368","https://openalex.org/W2076980800","https://openalex.org/W2080199790","https://openalex.org/W2090651425","https://openalex.org/W2103023362","https://openalex.org/W2116996913","https://openalex.org/W2127150747","https://openalex.org/W2158208985","https://openalex.org/W2172433780","https://openalex.org/W2412979653","https://openalex.org/W2413342671","https://openalex.org/W2420677971","https://openalex.org/W2470726881","https://openalex.org/W2885344167","https://openalex.org/W2897569659","https://openalex.org/W4206300092","https://openalex.org/W7220705626"],"related_works":["https://openalex.org/W2159439342","https://openalex.org/W319702132","https://openalex.org/W2412979653","https://openalex.org/W2020148470","https://openalex.org/W1964478422","https://openalex.org/W2046700897","https://openalex.org/W2887738254","https://openalex.org/W2055023916","https://openalex.org/W2046858002","https://openalex.org/W2010004974"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2000489601","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":1}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
